Cite
HARVARD Citation
Poveda, A. et al. (2021). Olaparib Tablets as Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a BRCA1/2 Mutation (SOLO2/ENGOT-Ov21): A Final Analysis of a Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial. Obstetrical & gynecological survey. 76 (9), pp. 535-536. [Online].